ID: MRFR/HC/8291-HCR | February 2023 | Region: Global | 120 Pages
The COVID-19 Sample Collection Kits Market is expected to reach at value of USD 3.12 Billion by 2030 and projected to grow at highest CAGR of 4.90%.
$3.12 Billion
4.90%
North America
2022 to 2030
COVID-19 Sample Collection Kits Market is expected to hold a value of USD 3.12 Billion by 2030 and COVID-19 Sample Collection Kits Market is expected to register a growth of 4.90% from 2020 to 2030.
Market Synopsis
The sample collection kit means the vitals and reagents provided for use in collecting samples and shipping them to the laboratory at which the testing services will be performed on such a sample. The high demand for sample collection kits, due to the outbreak of COVID-19 globally, and approval of new & advanced detection tests by authorities are the key factors that are expected to drive the COVID-19 sample collection kits market growth. The Food and Drug Administration (FDA), in May 2020, has issued an emergency use authorization (EUA) to Everlywell, Inc. for the COVID-19 Test Home Collection Kit. The product is a standalone, at home, nasal swab sample collection kit that can be sent to specified labs for subsequent COVID-19 diagnostic testing. Thus, there is an increase in demand for sample collection kits. Moreover, the detection of antibodies, rise in government funding, and large volume of products & usage rate of swabs are also expected to boost the COVID-19 sample collection kits market growth.
Market Influencer
The outbreak of COVID-19, leading to increased demand for the COVID-19 sample collection kit market.
Market Drivers
Market Restraints
COVID-19 sample collection kits MarketSegmentation
By Product Type
By Application
By End-User
By Region
COVID-19 Sample Collection Kits Market Key Players
Report Attribute/Metric | Details |
Market Size | 2030: USD 3.12 Billion |
CAGR | 4.90% (2022-2030) |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type and Application |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California). |
Key Market Opportunities | The Outbreak of COVID-19, Leading to Increased Demand for the COVID-19 Sample Collection Kit. |
Key Market Drivers | Approval of Detection Tests by Regulatory Authorities. Large Volume and Usage Rate of Swabs. Rise in the Detection of Antibodies. Increase in Government Funding. Rise in at-home kits for reducing the risk of transmitting the virus.\r\n |
The sample collection kit means the vitals and reagents provided for use in collecting samples and shipping them to the laboratory at which the testing services will be performed on such a sample.
Swabs are a small piece of soft material used for cleaning a cut or for taking a small amount of substance from a body, or the substance itself that can be tested. According to the Centers for Disease Control and Prevention (CDC), May 2020 report, sterile swabs for upper respiratory specimen collection can be packaged in two ways i.e., individually wrapped and bulk packaged.
COVID-19 Sample Collection Kits Market is expected to hold a value of USD 3.12 Billion by 2027 and is expected to register a growth of 4.90% from 2022 to 2030.
COVID-19 Sample Collection Kits Market is expected to hold a value of USD 3.12 Billion by 2030
COVID-19 Sample Collection Kits Market is expected to register a growth of 4.90% By 2030
High demand for sample collection kits, due to the outbreak of COVID-19 globally. Approval of detection tests by regulatory authorities. Large volume and usage rate of swabs. Rise in the detection of antibodies Increase in government funding. Rise in at-home kits for reducing the risk of transmitting the virus.
On the basis of product type, the market has been segmented into swabs, viral transport media, blood collection kits, and others. The swabs segment is anticipated to be the fastest-growing segment
Some of the key players in the global COVID-19 sample collection kits market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California)